• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Survey from Qualio Finds 50%+ of U.S. Consumers Refuse To Use a Healthcare Prescription or Product After a Recall


Qualio — the trusted cloud quality management system software for the entire life sciences ecosystem — announced a new survey of 2,002 U.S. consumers of healthcare products.

Qualio led this survey to better understand how far-reaching quality-related product recalls are when it comes to consumer trust and healthcare-specific purchasing decisions.

The survey uncovered that recalls and related quality issues have a pronounced and enduring impact on purchases of drugs, devices, therapies, and other healthcare products. Overall, survey data found that more than half (51%) of U.S. adults are unlikely to use a prescription drug that has experienced a recall, regardless of whether that issue was fixed. The same amount (51%) also indicated they'd unlikely use a recalled non-prescription healthcare product (e.g., over-the-counter medication, supplements/vitamins, skin products) after a recall.

For more insights and data from this survey, please visit qualio.com/resources/quality-consumer-report.

Related Videos
Related Content